Published in Eur J Immunol on November 01, 1986
B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci U S A (1989) 1.66
Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer. Nat Commun (2011) 1.49
Direct evidence for functional self-protein/Ia-molecule complexes in vivo. Proc Natl Acad Sci U S A (1988) 1.48
Specialized functions of MHC class I molecules. I. An N-formyl peptide receptor is required for construction of the class I antigen Mta. J Exp Med (1990) 1.32
Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response. Proc Natl Acad Sci U S A (1996) 1.27
Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. Proc Natl Acad Sci U S A (1994) 1.17
Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J (1993) 1.15
How Do CD4(+) T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules? Front Immunol (2014) 1.14
Minimum length of an idiotypic peptide and a model for its binding to a major histocompatibility complex class II molecule. EMBO J (1989) 1.08
Lymphomas can develop from B cells chronically helped by idiotype-specific T cells. J Exp Med (2007) 1.05
ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int (2008) 1.02
Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells. Proc Natl Acad Sci U S A (2000) 0.96
MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation. J Exp Med (1990) 0.93
Adoptive T-cell therapy for B-cell malignancies. Expert Rev Hematol (2009) 0.88
Diversification of the Ig variable region gene repertoire of synovial B lymphocytes by nucleotide insertion and deletion. Mol Med (2003) 0.87
The principle of delivery of T cell epitopes to antigen-presenting cells applied to peptides from influenza virus, ovalbumin, and hen egg lysozyme: implications for peptide vaccination. Proc Natl Acad Sci U S A (2001) 0.84
Tracking early autoimmune disease by bioluminescent imaging of NF-kappaB activation reveals pathology in multiple organ systems. Am J Pathol (2009) 0.84
Targeted DNA vaccines for enhanced induction of idiotype-specific B and T cells. Front Oncol (2012) 0.84
Cytotoxic T cells generated against heteroclitic peptides kill primary tumor cells independent of the binding affinity of the native tumor antigen peptide. Blood (2006) 0.83
Nuclear myxovirus-resistance protein Mx is a minor histocompatibility antigen. Proc Natl Acad Sci U S A (1990) 0.82
Protective role of anti-idiotypic antibodies in autoimmunity--lessons for type 1 diabetes. Autoimmunity (2012) 0.82
Chaperone-assisted thermostability engineering of a soluble T cell receptor using phage display. Sci Rep (2013) 0.81
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study. Cancer Immunol Immunother (2015) 0.81
Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA. BMC Biotechnol (2010) 0.78
Heterodimeric barnase-barstar vaccine molecules: influence of one versus two targeting units specific for antigen presenting cells. PLoS One (2012) 0.78
Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells. Immunology (2000) 0.77
Idiotype-specific CD4(+) T cells eradicate disseminated myeloma. Leukemia (2015) 0.77
Systemic Lupus Erythematosus: Molecular Mimicry between Anti-dsDNA CDR3 Idiotype, Microbial and Self Peptides-As Antigens for Th Cells. Front Immunol (2015) 0.76
Stabilizing mutations increase secretion of functional soluble TCR-Ig fusion proteins. BMC Biotechnol (2010) 0.76
SH2D2A modulates T cell mediated protection to a B cell derived tumor in transgenic mice. PLoS One (2012) 0.76
Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals. Scand J Immunol (2011) 0.75
Genes predisposing to autoimmunity augment constitutive major histocompatibility complex class II-associated presentation of the self-antigen IgG2a in vivo. Immunology (2000) 0.75
Immunogenicity of Isogenic IgG in Aggregates and Immune Complexes. PLoS One (2017) 0.75
Activation of idiotype-specific CD4+ T-cell line: cellular processing of exogenous self-immunoglobulin. Immunology (1990) 0.75
Tregitopes and impaired antigen presentation: Drivers of the immunomodulatory effects of IVIg? Immun Inflamm Dis (2017) 0.75
In Silico Prediction Analysis of Idiotope-Driven T-B Cell Collaboration in Multiple Sclerosis. Front Immunol (2017) 0.75
Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell (1991) 6.49
Genes of the major histocompatibility complex of the mouse. Annu Rev Immunol (1983) 4.44
Major histocompatibility complex-linked immune-responsiveness is acquired by lymphocytes of low-responder mice differentiating in thymus of high-responder mice. Proc Natl Acad Sci U S A (1978) 4.33
Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes. Nature (1981) 4.26
Transfer of specificity by murine alpha and beta T-cell receptor genes. Nature (1986) 3.97
Exon/intron organization and complete nucleotide sequence of an HLA gene. Proc Natl Acad Sci U S A (1982) 3.72
Two gut intraepithelial CD8+ lymphocyte populations with different T cell receptors: a role for the gut epithelium in T cell differentiation. J Exp Med (1991) 3.63
Homing of a gamma delta thymocyte subset with homogeneous T-cell receptors to mucosal epithelia. Nature (1990) 3.55
Fine specificity of a continuously growing killer cell clone specific for H-Y antigen. Eur J Immunol (1979) 3.27
The T cell receptor/CD3 complex is composed of at least two autonomous transduction modules. Cell (1992) 3.11
Altered T cell development in mice with a targeted mutation of the CD3-epsilon gene. EMBO J (1995) 2.84
Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell (1991) 2.83
Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6Chi monocyte precursors. Mucosal Immunol (2012) 2.73
Regulation of TCR alpha and beta gene allelic exclusion during T-cell development. Immunol Today (1992) 2.71
The chemokine TECK is expressed by thymic and intestinal epithelial cells and attracts double- and single-positive thymocytes expressing the TECK receptor CCR9. Eur J Immunol (2000) 2.58
Limited diversity of the rearranged T-cell gamma gene. Nature (1985) 2.58
Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med (1997) 2.51
Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012. Euro Surveill (2013) 2.39
Tuberculosis contact investigation in low prevalence countries: a European consensus. Eur Respir J (2010) 2.38
Crystal structure of a T cell receptor bound to an allogeneic MHC molecule. Nat Immunol (2000) 2.37
Direct evidence for chromosomal inversion during T-cell receptor beta-gene rearrangements. Nature (1986) 2.33
CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature (1995) 2.15
Gene transfer of H-2 class II genes: antigen presentation by mouse fibroblast and hamster B-cell lines. Cell (1984) 2.12
Transfection of the CD8 gene enhances T-cell recognition. Nature (1987) 2.05
MHC class II-restricted presentation of intracellular antigen. Cell (1991) 2.01
Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes. Cell (1987) 2.00
The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors. J Exp Med (1999) 1.98
Derivation of a T cell hybridoma variant deprived of functional T cell receptor alpha and beta chain transcripts reveals a nonfunctional alpha-mRNA of BW5147 origin. Eur J Immunol (1989) 1.94
Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. J Exp Med (1979) 1.93
Separation of antigen-specific lymphocytes. I. Enrichment of antigen-binding cells. J Exp Med (1975) 1.93
Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens (1983) 1.87
Expression and function of transplantation antigens with altered or deleted cytoplasmic domains. Cell (1983) 1.86
H-2 gene complementation in cytotoxic T cell responses of female against male cells. Eur J Immunol (1977) 1.75
[New recommendations for contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Pneumologie (2011) 1.68
The complete sequence of the human beta-myosin heavy chain gene and a comparative analysis of its product. Genomics (1990) 1.67
B-lymphoma cells process and present their endogenous immunoglobulin to major histocompatibility complex-restricted T cells. Proc Natl Acad Sci U S A (1989) 1.66
Tuberculosis control in big cities and urban risk groups in the European Union: a consensus statement. Euro Surveill (2014) 1.66
H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity. J Exp Med (1992) 1.64
TCR/CD3 coupling to Fas-based cytotoxicity. J Exp Med (1995) 1.64
Human cytotoxic T cell structures associated with expression of cytolysis. I. Analysis at the clonal cell level of the cytolysis-inhibiting effect of 7 monoclonal antibodies. Eur J Immunol (1982) 1.62
CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. J Exp Med (2001) 1.61
Preferential positive selection of V alpha 2+ CD8+ T cells in mouse strains expressing both H-2k and T cell receptor V alpha a haplotypes: determination with a V alpha 2-specific monoclonal antibody. Eur J Immunol (1992) 1.58
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Involvement of both T cell receptor V alpha and V beta variable region domains and alpha chain junctional region in viral antigen recognition. Eur J Immunol (1991) 1.47
Essential role of CD8 palmitoylation in CD8 coreceptor function. J Immunol (2000) 1.46
Expression of specific cytolytic activity by H-2I region-restricted, influenza virus-specific T lymphocyte clones. J Exp Med (1985) 1.46
Non-deletional mechanisms of peripheral and central tolerance: studies with transgenic mice with tissue-specific expression of a foreign MHC class I antigen. Immunol Rev (1991) 1.43
Analysis of the expression and function of class-II major histocompatibility complex-encoded molecules by DNA-mediated gene transfer. Annu Rev Immunol (1986) 1.33
Avian influenza A(H5N1) in humans: new insights from a line list of World Health Organization confirmed cases, September 2006 to August 2010. Euro Surveill (2011) 1.33
Distinct mechanisms of extrathymic T cell tolerance due to differential expression of self antigen. Int Immunol (1992) 1.32
Mortality of 2009 pandemic influenza A(H1N1) in Germany. Euro Surveill (2010) 1.32
Self-tolerance to transgenic gamma delta T cells by intrathymic inactivation. Nature (1990) 1.32
Suppression of T cell responses through competition for T cell growth factor (interleukin 2). Eur J Immunol (1982) 1.30
Engineered secreted T-cell receptor alpha beta heterodimers. Proc Natl Acad Sci U S A (1991) 1.30
Tyrosine-phosphorylated T cell receptor zeta chain associates with the actin cytoskeleton upon activation of mature T lymphocytes. Immunity (1995) 1.29
Gene transfer of the Ly-3 chain gene of the mouse CD8 molecular complex: co-transfer with the Ly-2 polypeptide gene results in detectable cell surface expression of the Ly-3 antigenic determinants. Eur J Immunol (1988) 1.29
Prevalence of cercariae from Lymnaea stagnalis snails in a pond system in Southern Germany. Parasitol Res (2001) 1.27
Different use of T cell receptor transducing modules in two populations of gut intraepithelial lymphocytes are related to distinct pathways of T cell differentiation. J Exp Med (1994) 1.27
CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity (1998) 1.27
Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay. J Immunol Methods (1982) 1.25
Expression of I-Ak class II genes in mouse L cells after DNA-mediated gene transfer. Nature (1983) 1.25
Dynamic adhesion of CD8-positive cells to antibody-coated surfaces: the initial step is independent of microfilaments and intracellular domains of cell-binding molecules. J Cell Biol (1994) 1.24
Ia-transfected L-cell fibroblasts present a lysozyme peptide but not the native protein to lysozyme-specific T cells. Proc Natl Acad Sci U S A (1985) 1.21
The 21- and 23-kD forms of TCR zeta are generated by specific ITAM phosphorylations. Nat Immunol (2000) 1.20
Cytotoxic T lymphocytes recognise allogeneic tolerated TNP-conjugated cells. Nature (1976) 1.18
Cotransfer of the Ed alpha and Ad beta genes into L cells results in the surface expression of a functional mixed-isotype Ia molecule. Proc Natl Acad Sci U S A (1986) 1.17
Naive idiotype-specific CD4+ T cells and immunosurveillance of B-cell tumors. Proc Natl Acad Sci U S A (1994) 1.17
Monoclonal antibodies raised against engineered soluble mouse T cell receptors and specific for V alpha 8-, V beta 2- or V beta 10-bearing T cells. Eur J Immunol (1991) 1.16
A signaling role for the cytoplasmic segment of the CD8 alpha chain detected under limiting stimulatory conditions. Proc Natl Acad Sci U S A (1990) 1.16
Absence of growth by most receptor-expressing fetal thymocytes in the presence of interleukin-2. Nature (1985) 1.15
A 55,000 Mr surface antigen on activated human T lymphocytes defined by a monoclonal antibody. Hum Immunol (1983) 1.14
Genomic organization of the mouse T cell receptor V alpha family. EMBO J (1990) 1.13
The role of idiotype-specific, CD4+ T cells in tumor resistance against major histocompatibility complex class II molecule negative plasmacytoma cells. Cell Immunol (1993) 1.12
The three-dimensional structure of a T-cell antigen receptor V alpha V beta heterodimer reveals a novel arrangement of the V beta domain. EMBO J (1997) 1.12
CD8 beta increases CD8 coreceptor function and participation in TCR-ligand binding. J Exp Med (1996) 1.11
H-2 restricted cytolytic and noncytolytic T cell clones: isolation, specificity and functional analysis. Immunol Rev (1981) 1.11
Phylogeography of Biomphalaria glabrata and B. pfeifferi, important intermediate hosts of Schistosoma mansoni in the New and Old World tropics. Mol Ecol (2003) 1.11
Separation of antigen-specific lymphocytes. II. Enrichment of hapten-specific antibody-forming cell precursors. J Exp Med (1975) 1.08
Clonal analysis of human T cell activation by the Mycoplasma arthritidis mitogen (MAS). Eur J Immunol (1988) 1.08
[Recommendations for environmental contact tracing in tuberculosis. German Central Committee against Tuberculosis]. Gesundheitswesen (2007) 1.08
Cytotoxic T cells recognize male antigen and H-2 as distinct entities. J Exp Med (1978) 1.07
Cytotoxic T cell responses to haptenated cells. III. Isolation and specificity analysis of continuously growing clones. Eur J Immunol (1980) 1.07
Completion of the nucleotide sequence of the Enterococcus faecalis conjugative virulence plasmid pAD1 and identification of a second transfer origin. Plasmid (2001) 1.07
Capture-recapture analysis to estimate the incidence of invasive meningococcal disease in Germany, 2003. Epidemiol Infect (2006) 1.07
Natural and engineered disorders of lymphocyte development. Science (1998) 1.07
Established murine cytolytic T-cell lines as tools for a somatic cell genetic analysis of T-cell functions. Immunol Rev (1980) 1.07
Double-negative thymocyte subsets in CD3 zeta chain-deficient mice: absence of HSA+CD44-CD25- cells. Eur J Immunol (1994) 1.07
Inhibition of human T cell mediated cytolysis by monoclonal antibodies to effector cell surface structures. Adv Exp Med Biol (1982) 1.07
A versatile method to produce antibodies to human T cell receptor V beta segments: frequency determination of human V beta 2+ T cells that react with toxic-shock syndrome toxin-1. Eur J Immunol (1992) 1.06
A CD8 genomic fragment that directs subset-specific expression of CD8 in transgenic mice. J Immunol (1997) 1.06
Characterization of cloned murine cytolytic T cell lines. J Immunol (1980) 1.04
T cell development and T cell responses in mice with mutations affecting tyrosines 292 or 315 of the ZAP-70 protein tyrosine kinase. J Exp Med (2001) 1.04
CTLA-1 and CTLA-3 serine esterase transcripts are detected mostly in cytotoxic T cells, but not only and not always. J Immunol (1987) 1.03
T cell clones: their use for the study of specificity, induction, and effector-function of T cells. Springer Semin Immunopathol (1980) 1.03
[Epidemiological characteristics of the influenza pandemic (H1N1) 2009 in Germany based on the mandatory notification of cases]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2010) 1.02
Crippling of CD3-zeta ITAMs does not impair T cell receptor signaling. Immunity (1999) 1.02